Texas Instruments Incorporated (TXN)

Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.

Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.

Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

Dividend growth of 13.02% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.

Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.

Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.

Positive 10Y revenue/share CAGR while QRVO is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.

Positive 5Y CAGR while QRVO is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.

Positive 3Y CAGR while QRVO is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.

10Y OCF/share CAGR above 1.5x QRVO's 35.19%. David Dodd would check if a superior product mix or cost edge drives this outperformance.

5Y OCF/share CAGR 1.25-1.5x QRVO's 35.19%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.

3Y OCF/share CAGR 1.25-1.5x QRVO's 35.19%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.

Net income/share CAGR above 1.5x QRVO's 97.08% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.

3Y net income/share CAGR above 1.5x QRVO's 97.08%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.

Positive growth while QRVO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.

Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.

Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.

Dividend/share CAGR of 1232.73% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.

Dividend/share CAGR of 183.53% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.

3Y dividend/share CAGR of 100.21% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.

Firm’s AR is declining while QRVO shows 4.81%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.

We show growth while QRVO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.

Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.

Positive BV/share change while QRVO is negative. John Neff sees a clear edge over a competitor losing equity.

We’re deleveraging while QRVO stands at 1.58%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.